Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.msard.2020.102347 http://scihub22266oqcxt.onion/10.1016/j.msard.2020.102347 32645636!?!32645636 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32645636&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mult+Scler+Relat+Disord 2020 ; 45 (?): 102347 Nephropedia Template TP {{tp|p=32645636|t=2020. The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study |pdf=|usr=}}{{32645636}} gab.com Text The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study JO: Mult Scler Relat Disord http://www.kidney.de/pget.php?&tw=1&pmid=32645636 #FOAvip Neuromyelitis optica spectrum disorder (NMOSD) is a CNS neuroinflammatory disorder, mediated by the pathogenic autoantibody aquaporin-4 (AQP4-IgG). Current treatment includes long-term use of immunomodulatory therapies, leading to increased rates of infections among this population. It is of interest therefore, to study how the COVID-19 pandemic affects NMOSD patients in terms of their disease activity. A 15-point questionnaire was administered to 33 participants living in Northern California with NMOSD, MS and other related disorders. Although none of the participants were diagnosed with COVID-19, our results show that 2 participants with NMOSD experienced new onset of neurological symptoms and 2 experienced worsening of previous neurological symptoms - suggesting a possible effect of pandemic-related stress on this CNS autoimmune disorder. Twit Text FOAVip The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study ????Mult Scler Relat Disord http://www.kidney.de/pget.php?&tw=1&pmid=32645636 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32645636 #FOAvip English Wikipedia <ref>{{Cite pmid|32645636}}</ref> The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study #MMPMID32645636 Tomczak A; Han MH Mult Scler Relat Disord 2020[Oct]; 45 (?): 102347 PMID32645636show ga Neuromyelitis optica spectrum disorder (NMOSD) is a CNS neuroinflammatory disorder, mediated by the pathogenic autoantibody aquaporin-4 (AQP4-IgG). Current treatment includes long-term use of immunomodulatory therapies, leading to increased rates of infections among this population. It is of interest therefore, to study how the COVID-19 pandemic affects NMOSD patients in terms of their disease activity. A 15-point questionnaire was administered to 33 participants living in Northern California with NMOSD, MS and other related disorders. Although none of the participants were diagnosed with COVID-19, our results show that 2 participants with NMOSD experienced new onset of neurological symptoms and 2 experienced worsening of previous neurological symptoms - suggesting a possible effect of pandemic-related stress on this CNS autoimmune disorder. |*Psychological Distress[MESH] |*Symptom Flare Up[MESH] |Adult[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/*psychology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Neuromyelitis Optica/*complications[MESH] |Pandemics[MESH] |Pilot Projects[MESH] |Pneumonia, Viral/*epidemiology/*psychology[MESH] |SARS-CoV-2[MESH]The impact of COVID-19 on patients with neuromyelitis optica spectrum (epmc).pdf DeepDyve Pubget Overpricing